Filter
25
Filtered Results: 25
Text search:
Fairlie,
L.
Featured
Recommendations
6
New Publications
3
Language
Document type
No document type
11
Guidelines
10
Studies & Reports
4
Countries / Regions
Brazil
2
Thailand
1
Ukraine
1
Rwanda
1
Global
1
Authors & Publishers
Publication Years
Category
COVID-19
2
Guidelines
2
Demograhic Health Surveys DHS
1
Toolboxes
Children & Adolescents
4
Vaxzevria (Astra Zeneca)
4
Drug resistance
3
Infection Control General
3
Educational Settings
3
Workplace
3
Physical Distancing
3
ART Drug Resistance
2
Treatment & Prevention
2
General Reports
1
Clinical Aspects, Treatment & Prevention
1
HIV testing & disclosure
1
Children/Adolescents Mental Disorders
1
Adherence
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Non-pharmaceutical interventions (NPIs)
1
TB/HIV
1
Booster Doses
1
HIV and coinfection
1
TB/HIV Coinfection
1
Reports & Studies Children HIV
1
Reports & Studies
1
Eastern Europe and central Asia
1
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
